Systematic Review of Important Viral Diseases in Africa in Light of the ‘One Health’ Concept

Chauhan, Ravendra P.; Dessie, Zelalem G.; Noreddin, Ayman M.; Zowalaty, Mohamed E. El

doi:10.3390/pathogens9040301

Cited by 62 publications

(52 citation statements)

References 293 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After removing duplicates, the first search yielded eight systematic reviews 5,8‐14 . Three of them were eliminated because they did include information on clinical characteristics in children 8‐10 .…”

Section: Resultsmentioning

confidence: 99%

Asthma and COVID‐19 in children: A systematic review and call for data

Castro-Rodriguez

Forno

2020

Pediatric Pulmonology

108

View full text Add to dashboard Cite

Rationale Whether asthma constitutes a risk factor for coronavirus disease‐2019 (COVID‐19) is unclear. Here, we aimed to assess whether asthma, the most common chronic disease in children, is associated with higher COVID‐19 risk or severity in pediatric populations. Methods We performed a systematic literature search in three stages: first, we reviewed PubMed, EMBASE, and CINAHL for systematic reviews of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and COVID‐19 in pediatric populations, and reviewed their primary articles; second, we searched PubMed for studies on COVID‐19 or SARS‐CoV‐2 and asthma/wheeze, and evaluated whether the resulting studies included pediatric populations; third, we repeated the second search in http://BioRxiv.org and http://MedRxiv.org to find pre‐prints that may have information on pediatric asthma. Results In the first search, eight systematic reviews were found, of which five were done in pediatric populations; none of the 67 primary studies included data on pediatric asthma as a comorbidity for COVID‐19. In the second search, we found 34 results in PubMed, of which five reported asthma in adults, but none included data on children. In the third search, 25 pre‐prints in MedRxiv included data on asthma, but none on children. We found one report by the US Centers for Disease Control and Prevention stating that 40/345 (~11.5%) children with data on chronic conditions had “chronic lung diseases including asthma,” and one from a tertiary hospital in New York that reported asthma in 11/46 (~23.9%) children hospitalized for COVID‐19. Conclusion There is scarcely any data on whether childhood asthma (or other pediatric respiratory diseases) constitute risk factors for SARS‐CoV‐2 infection or COVID‐19 severity. Studies are needed that go beyond counting the number of cases in the pediatric age range.

show abstract

Section: Resultsmentioning

confidence: 99%

Asthma and COVID‐19 in children: A systematic review and call for data

Castro-Rodriguez

Forno

2020

Pediatric Pulmonology

108

View full text Add to dashboard Cite

show abstract

“…This will be the first paper in this series as more information and findings become available. This builds on a recent systematic review regarding the importance of viral diseases in Africa, and the fact that different approaches will be needed across Africa to tackle COVID-19, depending on current circumstances (Chauhan et al, 2020;Mehtar et al, 2020;Shepherd and van der Mark, 2020).…”

Section: Rationale Behind the Paper And The Objectivementioning

confidence: 99%

Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future

Ogunleye

Basu

Mueller³

et al. 2020

Front. Pharmacol.

167

215

View full text Add to dashboard Cite

Background: The COVID-19 pandemic has already claimed considerable lives. There are major concerns in Africa due to existing high prevalence rates for both infectious and non-infectious diseases and limited resources in terms of personnel, beds and equipment. Alongside this, concerns that lockdown and other measures will have on prevention and management of other infectious diseases and non-communicable diseases (NCDs). NCDs are an increasing issue with rising morbidity and mortality rates. The World Health Organization (WHO) warns that a lack of nets and treatment could result in up to 18 million additional cases of malaria and up to 30,000 additional deaths in sub-Saharan Africa. Objective: Document current prevalence and mortality rates from COVID-19 alongside economic and other measures to reduce its spread and impact across Africa. In addition, suggested ways forward among all key stakeholder groups. Our Approach: Contextualise the findings from a wide range of publications including internet-based publications coupled with input from senior-level personnel. Ongoing Activities: Prevalence and mortality rates are currently lower in Africa than among several Western countries and the USA. This could be due to a number of factors including early instigation of lockdown and border closures, the younger age of the population, lack of robust reporting systems and as yet unidentified genetic and other factors. Innovation is accelerating to address concerns with available equipment. There are ongoing steps to address the level of misinformation and its consequences including fines. There are also ongoing initiatives across Africa to start addressing the unintended consequences of COVID-19 activities including lockdown measures and their impact on Ogunleye et al. COVID-19 in Africa NCDs including the likely rise in mental health disorders, exacerbated by increasing stigma associated with COVID-19. Strategies include extending prescription lengths, telemedicine and encouraging vaccination. However, these need to be accelerated to prevent increased morbidity and mortality. Conclusion: There are multiple activities across Africa to reduce the spread of COVID-19 and address misinformation, which can have catastrophic consequences, assisted by the WHO and others, which appear to be working in a number of countries. Research is ongoing to clarify the unintended consequences given ongoing concerns to guide future activities. Countries are learning from each other.

show abstract

Section: Resultsmentioning

confidence: 99%

“…After removing duplicates, the first search yielded eight systematic reviews [5,[7][8][9][10][11][12][13]. Three of them were eliminated because they did include information on clinical characteristics in children [7][8][9]. Therefore, we evaluated five systematic reviews done at different periods during the pandemic and thus including somewhat different primary studies [10][11][12][13] [13] included 45 studies from China (the total number of patients was not described) up to March 19, 2020.…”

Section: Resultsmentioning

confidence: 99%

Asthma and COVID-19 in children – a systematic review and call for data

Castro-Rodriguez

Forno

2020

Preprint

View full text Add to dashboard Cite

Rationale:Whether asthma constitutes a risk factor for COVID-19 is unclear. Methods:We performed a systematic literature search in three stages: First, we reviewed PubMed, EMBASE and CINAHL for systematic reviews of SARS-CoC-2 and COVID-19 in pediatric populations, and reviewed their primary articles; next, we searched PubMed for studies on COVID-19 or SARS-CoV-2 and asthma/wheeze, and evaluated whether the resulting studies included pediatric populations; lastly, we repeated the second search in BioRxiv.org and MedRxiv.org to find pre-prints that may have information on pediatric asthma. Results:In the first search, eight systematic reviews were found, of which five were done in pediatric population; after reviewing 67 primary studies we found no data on pediatric asthma as a comorbidity for COVID-19. In the second search, we found 25 results in PubMed, of which five reported asthma in adults, but none included data on children. In the third search, 14 preprints in MedRxiv were identified with data on asthma, but again none with pediatric data. We found only one report by the U.S. CDC stating that 40/345 (~11.5%) children with data on chronic conditions had "chronic lung diseases including asthma". Conclusion:There is scarcely any data on whether childhood asthma (or other pediatric respiratory diseases) constitute risk factors for SARS-CoV-2 infection or COVID-19 severity. Studies are needed that go beyond counting the number of cases in the pediatric age range.

show abstract

Systematic Review of Important Viral Diseases in Africa in Light of the ‘One Health’ Concept

Cited by 62 publications

References 293 publications

Asthma and COVID‐19 in children: A systematic review and call for data

Asthma and COVID‐19 in children: A systematic review and call for data

Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future

Asthma and COVID-19 in children – a systematic review and call for data

Contact Info

Product

Resources

About